“We hope this is just the beginning of a fruitful, ongoing partnership with Duke, UNC, and the NC Biotech Center.” The Spring event was focused on therapeutics, while this iteration was geared toward ...

This slows moisture loss and keeps the yolk centered." It's also important to store eggs in the coldest part of your fridge rather than the door, since the temperature fluctuates in that area ...

HOUSTON, TX / ACCESSWIRE / October 30, 2024 / Amid a supply chain crisis, hospitals nationwide are preparing ... and healthcare providers are once again turning to US Med-Equip (USME) to ensure they ...

HOUSTON, TX / ACCESSWIRE / October 30, 2024 / Amid a supply chain crisis ... and healthcare providers are once again turning to US Med-Equip (USME) to ensure they have the critical equipment ...

AMA membership offers unique access to savings and resources tailored to enrich the personal and professional lives of physicians, residents and medical students ... for the supply chain. We know that ...

Boston IVF to begin providing FemaSeed as an infertility treatment option to expand access for patients across nearly 30 centers nationwide ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., ...

Syngene (CMP: Rs 875; Market cap: Rs 35,216 crore; Rating: Overweight), the leading CRAMS (contract research and manufacturing services) player, posted a sequential growth in its Q2FY25 results.

Ashwin Ramaswami, a young Democrat from Johns Creek, is challenging the incumbent state senator, who was indicted alongside former President Trump for alleged interference in Georgia's 2020 election.

This move will significantly enhance the company's ability to advance the use of proteomics as a vital tool for the pharmaceutical and biotech industries. Building on recent strategic initiatives ...

This website uses cookies to improve your experience. By continuing to use this website you are accepting our cookie policy. Some cookies are necessary to make the website work properly, for example ...

However, the biotech has what it takes to be successful in the challenging gene-editing niche. This company might be worth far more than many realize. If I had to buy one share of any biotech with ...

US privately-held drug developer NImmune Biopharma has acquired development and commercialization rights for omilancor in Asia from Sino-American biotech LianBio. The covered markets include China, ...